NTM species (number of isolates tested) | Resistant (R) or susceptible (S) | Percentage of strains resistant or susceptible for each antimicrobial agent | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Amikacin | Kanamycin | Tobramycin | Doxycycline | Clarithromycin | Ciprofloxacin | Sulfamethoxazole | Rifampicin | Isoniazid | ||
R | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |||||
I | 100.00 | |||||||||
S | 100.00 | 100.00 | 100.00 | |||||||
R | 6.25 | 43.75 | 100.00 | 6.25 | 100.00 | 100.00 | 100.00 | 100.00 | ||
I | 12.50 | 12.50 | 50.00 | |||||||
S | 81.25 | 87.50 | 6.25 | 93.75 | ||||||
R | 10.00 | 100.00 | 90.00 | 50.00 | 10.00 | 10.00 | 100.00 | 100.00 | ||
I | 10.00 | 40.00 | ||||||||
S | 90.00 | 90.00 | 10.00 | 10.00 | 90.00 | 90.00 | ||||
R | 20.00 | 6.67 | 20.00 | 93.33 | 100.00 | |||||
I | 46.67 | |||||||||
S | 100.00 | 100.00 | 33.33 | 100.00 | 93.33 | 80.00 | 100.00 | 6.67 | ||
R | 3.03 | 9.09 | 12.12 | 93.94 | 100.00 | |||||
I | 87.88 | 3.03 | ||||||||
S | 100.00 | 100.00 | 9.09 | 90.91 | 96.97 | 87.88 | 100.00 | 6.06 | ||
R | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |||||
I | 100.00 | |||||||||
S | 100.00 | 100.00 | 100.00 | |||||||
R | 100.00 | 100.00 | ||||||||
I | ||||||||||
S | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |||
R | 8.33 | 8.33 | 8.33 | 66.67 | 8.33 | 8.33 | 100.00 | 100.00 | ||
I | 33.33 | 8.33 | 8.33 | |||||||
S | 91.67 | 91.67 | 58.33 | 25.00 | 83.34 | 91.67 | 100.00 | |||
R | 100.00 | 100.00 | 100.00 | |||||||
I | ||||||||||
S | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | ||||
R | 100.00 | 100.00 | 100.00 | 100.00 | ||||||
I | 100.00 | 100.00 | ||||||||
S | 100.00 | 100.00 | 100.00 | |||||||
R | 25.00 | 25.00 | 75.00 | 25.00 | 100.00 | 100.00 | ||||
I | 25.00 | 25.00 | ||||||||
S | 100.00 | 100.00 | 75.00 | 75.00 | 75.00 | 75.00 | ||||
R | 50.00 | 100.00 | 100.00 | |||||||
I | 50.00 | 50.00 | ||||||||
S | 100.00 | 100.00 | 100.00 | 100.00 | 50.00 | 100.00 | ||||
R | 100.00 | 100.00 | 100.00 | |||||||
I | ||||||||||
S | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Antimicrobial agent | Susceptibility |
|||||
---|---|---|---|---|---|---|
RGM (n = 50) |
SGM (n = 49) |
|||||
S | I | R | S | I | R | |
AMK | 90.00 | 4.00 | 6.00 | 100 | 0.00 | 0.00 |
KAN | 92.00 | 6.00 | 2.00 | 100 | 0.00 | 0.00 |
TOB | 32.00 | 28.00 | 40.00 | 16.33 | 73.47 | 10.20 |
DOX | 18.00 | 4.00 | 78.00 | 93.88 | 0.00 | 6.12 |
CLR | 72.00 | 12.00 | 16.00 | 95.92 | 2.04 | 2.04 |
CIP | 48.00 | 8.00 | 44.00 | 83.67 | 0.00 | 16.33 |
SMX | 60.00 | 0.00 | 40.00 | 100.00 | 0.00 | 0.00 |
RMP | 0.00 | 0.00 | 100.00 | 6.12 | 0.00 | 93.88 |
INH | 0.00 | 0.00 | 100.00 | 2.04 | 0.00 | 97.96 |
Antimicrobial agent | Range (μg/mL) | MIC breakpoints (μg/mL) |
|||||
---|---|---|---|---|---|---|---|
RGM |
SGM |
||||||
S | I | R | S | I | R | ||
AMK | 1–128 | ≤16 | 32 | ≥64 | - | - | >32 |
KAN | 1–64 | ≤16 | 32 | ≥64 | - | - | >32 |
TOB | 1–64 | ≤1 | 2–4 | ≥8 | - | - | >4 |
DOX | 0.25–32 | ≤2 | 4 | ≥8 | ≤2 | 4 | ≥8 |
CLR | 0.25–32 | ≤2 | 4 | ≥8 | ≤8 | 16 | ≥32 |
CIP | 0.125–16 | ≤1 | 2 | ≥4 | - | - | >2 |
SMX | 1–64 | ≤32 | - | ≥64 | ≤32 | - | ≥64 |
RMP | 0.25–64 | - | - | >1 | - | - | >1 |
INH | 1–64 | - | - | ≥5 | - | - | ≥5 |